Philip Morris (PM) Offering Possible 45.35% Return Over the Next 8 Calendar Days

Philip Morris's most recent trend suggests a bearish bias. One trading opportunity on Philip Morris is a Bear Call Spread using a strike $77.00 short call and a strike $82.00 long call offers a potential 45.35% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $77.00 by expiration. The full premium credit of $1.56 would be kept by the premium seller. The risk of $3.44 would be incurred if the stock rose above the $82.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Philip Morris is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Philip Morris is bearish.

The RSI indicator is at 68.4 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Philip Morris

What's Next for Altria (MO) Stock After Kroger (KR), Walmart (WMT), and Other Retailers Abandon E-Cigarette Sales?
Tue, 08 Oct 2019 16:50:46 +0000
Supermarket giant Kroger (KR) became the latest retailer to discontinue the sale of electronic cigarettes amid regulatory scrutiny.

NewsBreak: Tobacco Stocks Mixed as Research Links E-Cigarettes to Cancer in Mice
Mon, 07 Oct 2019 20:31:01 +0000
Investing.com – Tobacco stocks were mixed amid new findings showing that exposure to nicotine in e-cigarette vapor had caused cancer in mice, and was likely “very harmful” to humans, according to New York University.

This Week’s Top Wall Street Upgrades: VMW, NXPI, PM
Fri, 04 Oct 2019 22:51:55 +0000
Stocks go up, stocks go down — and so do analysts' opinions of them. This series looks at which upgrades investors should act on. Specifically, we'll find out why analysts are revving their engines for VMware, NXP Semiconductors NV and Philip Morris.Let's take a closer look:VMware (VMW)First up, 5-star Wells Fargo analyst Philip Winslow upped his rating on VMware to 'buy' Tuesday. According to Winslow, the company behind everything from cloud to networking and security to digital workspace is worth about 17% more than it's currently selling for, and should hit $180 within the next 12 months. (To watch Winslow's track record, click here)Winslow wrote, "Although VMware’s core server virtualization business (vSphere) has performed well recently as existing customers continue to invest in their VMware infrastructure and the traction of newer products (NSX, vSAN, and vRealize) and services has been impressive, many investors have been concerned that the growing interest in deploying cloud-native and containerized applications into Kubernetes-centric environments will eventually reduce the relevancy of and customer demand for VMware’s virtualization-centric product portfolio. Conversely, we believe the acquisitions of Bitnami, Heptio, and Pivotal Software, combined with the release of VMware Tanzu (particularly Project Pacific), will position VMware to emerge as the leader in the market for Kubernetes-based, multi-cloud platform solutions."Overall, the word on the Street rings largely bullish on this cloud computing giant, backing Winslow's confident move, with TipRanks analytics demonstrating VMW as a Buy. Out of 23 analysts polled in the last 3 months, 16 are bullish on VMware stock, 9 remain sidelined, and only one is bearish on the stock. With a return potential of nearly 14%, the stock's consensus target price stands at $175.83. (See VMW's price targets and analyst ratings on TipRanks)NXP Semiconductors (NXPI)Investors may have better luck investing in our second stock of the day, NXP Semiconductors, which was upgraded to 'buy' this week by 5-star analyst Weston Twigg at KeyBanc. According to the analyst, this chip stock with the $110 stock price will rise to $130 a share within a year. (To watch Twigg's track record, click here)Twigg commented, "We believe demand trends at NXPI have bottomed and channel inventories for the Company have begun to normalize. While we had previously had concerns regarding the impact of the pending QCOM acquisition on the Company’s design pipeline, we believe these concerns are already reflected in the Company’s current valuation (12x P/E 2020) and also believe NXPI’s pending acquisition of MRVL’s connectivity assets will partially offset this. While demand trends in automotive remain weak, we like the Company’s outsized exposure to this segment (50% of revenues) longer term, and see opportunities for the Company to offset weak end demand via content growth associated with design wins within: 1) ADAS; 2) BMS (battery management systems) and the associated electrification of autos; and 3) Infotainment."All in all, cautious optimism circles this semiconductor player, as TipRanks analytics exhibit NXPI as a Moderate Buy. Out of 12 analysts polled in the last 3 months, 7 are bullish on NXP Semiconductors stock, while 5 remain sidelined. With a return potential of 5.5%, the stock’s consensus target price stands at $115.91. (See NXPI's price targets and analyst ratings on TipRanks)Philip Morris (PM)A third stock worthy of consideration — at least, Wall Street thinks so — is Philip Morris. This week, BofA/Merrill Lynch analyst Lisa Lewandowski upgraded the tobacco titan from 'neutral' to 'buy', predicting PM shares will hit $96 a share a year from now. (To watch Lewandowski's track record, click here)Lewandowski explained, "While vaping issues may drag on the industry as whole near-term, they think PM will eventually rise above the noise given their lack of US vaping exposure. while merger talks shook investors, they see see PM’s underlying fundamentals as strong with upside potential as consumers look for alternatives as vaping products remain in the eye of the media storm. Given its attractive valuation, pricing power, IQOS’ growth trajectory & commitment to shareholder returns (yield 6.2%), we are upgrading PM from Neutral to Buy."The Street largely seems to echo Lewandowski positive sentiment, considering TipRanks analytics showcase PM as a Buy. Out of 12 analysts polled in the last 3 months, 9 are bullish on Philip Morris stock, 2 remain sidelined, and only one is bearish on the stock. With a potential upside of about 20%, the stock’s consensus target price stands at $94.17. (See PM's price targets and analyst ratings on TipRanks)

E-Cigarette Sales Are Holding Up as Pressure Mounts on Vaping
Fri, 04 Oct 2019 17:05:00 +0000
Increasing calls to regulate e-cigarettes and vaping products may be worrying investors, but Raymond James notes that sales haven’t dropped yet.

The Zacks Analyst Blog Highlights: Bank of America, Home Depot, Philip Morris, NextEra and Eli Lilly
Fri, 04 Oct 2019 12:30:12 +0000
The Zacks Analyst Blog Highlights: Bank of America, Home Depot, Philip Morris, NextEra and Eli Lilly

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.